DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|5|4|357-365

ISSN： 1389-4501

Source： Current Drug Targets, Vol.5, Iss.4, 2004-05, pp. : 357-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-Ribose) Polymerase Inhibitors

By  

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 321-340

Bentham Science Publishers

Access to resources Recommend Favorite

The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment

By  

Current Drug Targets, Vol. 12, Iss. 14, 2011-01 ,pp. : 2034-2044

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of poly(ADP-ribose) polymerase (PARP)

By Peukert Stefan   Schwahn Uwe  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1531-1551

Informa Healthcare

Access to resources Recommend Favorite

Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress

By  

Current Pharmaceutical Biotechnology, Vol. 3, Iss. 3, 2002-09 ,pp. : 275-283

Bentham Science Publishers

Access to resources Recommend Favorite

Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9

By Srinivas G.   Anto R.J.   Srinivas P.   Vidhyalakshmi S.   Senan V.P.   Karunagaran D.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 117-125

Elsevier

Access to resources Recommend Favorite